Skip to content
Screener

Thermo Fisher Scientific TMO Life Sciences Solutions — Restructuring and other costs

Other segment segments

Laboratory Products and Biopharma Services
$33M
Analytical Instruments
$4M

Similar metrics at other companies

Oracle logo
ORCLCloud And License Business — Restructuring Reserve Accrual Adjustment1
-$2M-200%
Oracle logo
ORCLHardware Business — Restructuring Reserve Accrual Adjustment1
-$2M
Oracle logo
ORCLServices Business — Restructuring Reserve Accrual Adjustment1
-$11M
Hillman Solutions Corp. logo
HLMNRestructuring and other costs
$1.01M+36.3%
Clear Channel Outdoor Holdings, Inc. logo
CCORestructuring and other costs
$95K
MSC Industrial Direct Co. logo
MSMReportable Segment — Restructuring and other costs
$0-100%

Other financials

Income statement

See full
Revenue$12.0B
Operating income$2.1B
Net income$1.7B+7.4%
EPS (diluted)$4.68+9.3%

Balance sheet

See full
Cash & equivalents$4.1B-11.7%
Total debt$39.2B+4.6%
Total equity$52.7B+4.3%
Total assets$113.17B+11.8%

Cash flow

See full
Operating cash flow$2.1B+51.9%
CapEx-$1.2B-509%
Free cash flow$923.0M-16.5%

Valuation

See full
Market cap$214.46B+26.5%
Enterprise value$249.58B+23.3%
P/E30.8×+5.0×
P/S4.8×-0.9×

Profitability

See full
Gross margin58.3%
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp
FCF margin15.7%-2.1pp

Returns & leverage

See full
Return on equity13.5%+0.1pp
Debt / equity0.7×0.0×
Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept tmo:RestructuringAndOtherCostsIncomeNet.

The source filing: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 11:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000097745-26-000092
(In millions)Three months ended / March 28, 2026Three months ended / March 28, 2026
Life Sciences Solutions$$9
Analytical Instruments4
Laboratory Products and Biopharma Services33
Corporate3
$$49

Item 1. Financial Statements (Unaudited)

FAQ

What is Thermo Fisher Scientific's life sciences solutions — restructuring and other costs?
Thermo Fisher Scientific (TMO) reported life sciences solutions — restructuring and other costs of $9M in Q1 2026.
What is the long-term trend for Thermo Fisher Scientific's life sciences solutions — restructuring and other costs?
Over 3 years (2021 to 2024), Thermo Fisher Scientific's life sciences solutions — restructuring and other costs has grown at a -18.8% compound annual growth rate (CAGR), from $129M to $69M.
What does life sciences solutions — restructuring and other costs mean?
Expenses incurred by the Life Sciences Solutions segment related to organizational changes, such as facility consolidations, workforce reductions, or integration of acquired entities. These costs are typically non-recurring and aimed at improving long-term operational efficiency.

Ask your AI about Thermo Fisher Scientific's life sciences solutions — restructuring and other costs.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude